STAA Q4 2022 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q4 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$64M+8.5% YoY

Gross Profit

$50M77.7% margin

Operating Income

$964,0001.5% margin

Net Income

$6M9.1% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

-15.8%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

-$1M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$419M

Total Liabilities

$83M

Stockholders' Equity

$336M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$59M	+8.5%
Gross Profit	$50M	$45M	+10.7%
Operating Income	$964,000	$7M	-86.9%
Net Income	$6M	$5M	+18.9%

Revenue Segments

Implantable Collamer Lenses

$61M95%

Cataract Intraocular Lenses

$2M3%

Other Surgical Products

$884,0001%